First Opinion Michael Banks Improving the FDA-EMA parallel scientific advice program to advance complex generics
Biotech Elaine Chen, Andrew Joseph, and Adam Feuerstein STAT Plus: What to know about Alnylam’s upcoming readout on its heart drug
In the Lab Jonathan Wosen Teamwork is good for science — but maybe not for young researchers’ careers
Health tech Mohana Ravindranath STAT Plus: Q&A: How the FDA could use AI for drug and device safety surveillance
Politics Rachel Cohrs Zhang STAT Plus: Democratic platform favors slate of smaller goals over a health overhaul
Biotech Allison DeAngelis STAT Plus: AI drug firm Recursion seeks to move from survival to industry domination
Business Bob Herman STAT Plus: Peter Orszag wants the FTC and DOJ to stop challenging ‘vertical’ health care mergers
First Opinion Steffie Woolhandler, David U. Himmelstein, Elizabeth Schrier, and Hope Schwartz Private equity: health care’s vampire
Pharmalot Ed Silverman STAT Plus: Will the FTC challenge a deal that would give Novo Nordisk control of some Catalent plants?
Letters to the editor Patrick Skerrett First Opinion readers on Noah Lyles and Covid-19, the dearth of geriatricians, PBMs, and more
Exclusive Meghana Keshavan STAT Plus: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy
First Opinion Sarah Emond STAT Plus: What the newly released Medicare prices for 10 drugs do and don’t tell us
Politics Sarah Owermohle and Rachel Cohrs Zhang STAT Plus: Harris pledges to scrap billions in medical debt with new presidential platform
Health Theresa Gaffney More than 70 babies have been born from uterus transplants: ‘It’s a complete new world’
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about a Covid-flu shot setback, mpox vaccine supplies, and more
Biotech Matthew Herper STAT Plus: Pfizer and BioNTech effort to develop Covid-influenza combination vaccine sees setback
Health Timmy Broderick As climate changes, scorching summers bring deadly heat for people with disabilities
First Opinion Peter Staley Gilead must be held accountable for the harm caused by ‘patent hopping’ an HIV treatment
Health Nicholas St. Fleur The story of the giraffe, its neck, and a possible treatment for human heart disease
Health Helen Branswell To counter mpox, vaccine maker could ramp up by another 8 million doses next year
Health Timmy Broderick Clinical trials exclude disabled Americans because federal agencies failed them, new report finds
Hospitals Tara Bannow STAT Plus: UnitedHealthcare’s latest contract dispute, this time with Trinity Health, leaves thousands out-of-network